Navigation Links
Healthcare Tech and the World: Podcast Examines The Challenges & Opportunities for Change in the Healthcare Industry
Date:2/7/2008

Perot Systems Continues Its Thought Leadership Series with a Discussion

Between Dr. Kevin Fickenscher and Dr. Suzanne Delbanco

PLANO, Texas, Feb. 7 /PRNewswire-FirstCall/ -- Improving safety, quality and costs continue to be a major concern for leaders in today's Healthcare Industry. In this edition of Healthcare Tech and the World, Dr. Kevin Fickenscher, Chief Medical Officer & Executive Vice President of Healthcare Transformation for Perot Systems, discusses the challenges and opportunities for change with Dr. Suzanne Delbanco, one of the nation's leading voices for quality improvements in Healthcare.

According to Dr. Delbanco, "the aim (of her work) is to ultimately take advantage of the know-how and technology that exists today, that we know could make a huge difference, and get it implemented so that it can benefit a patient."

Dr. Delbanco is the former Executive Director of the Leapfrog Group, and the focus of her work consists in driving improvements in the Healthcare industry. Dr. Delbanco is on the board of Bridges to Excellence as well as Prometheus Payment, Inc. She has been a member of the NCQA Advisory Council, and previously worked with the Pacific Business Group on Health as a member of their Quality Team. Dr. Delbanco received both her MPH and Ph.D. from the University of California at Berkeley.

What: Healthcare Tech and the World: The Challenge and Opportunity

for Change in the Healthcare Industry -- one of a series of

podcasts presented by Dr. Kevin Fickenscher of Perot Systems --

Dr. Fickenscher's bio can be found at:

http://www.perotsystems.com/speakers/Kevin_Fickenscher_MD.htm

When: This podcast will be available for download on February 7, 2008

Where:

SOURCE Perot Systems
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
2. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
3. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
4. Dr. Paul Bandt Celebrates 35th Anniversary With Desert Radiologists and a History of Healthcare in Las Vegas
5. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
6. MDS to Present at Thomas Weisel Partners Healthcare Conference
7. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
8. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
9. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
10. Kingfisher Healthcare (KFH) Achieves World Class Quality Platform
11. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)....C., and BRUSSELS, BELGIUM A team of researchers ...t catholique de Louvain (UCL) has found that lacti...ls. In further experiments, they discovered a new ...mor cells by preventing them from delivering lacti...s that low-oxygen, or hypoxic, cells cause resista...
(Date:11/20/2008)...er 5, the Johns Hopkins Bloomberg School of Public...host a half-day symposium to mark the 60th Anniver... The event, "Public Health and Human Rights: The W... health and human rights over the last 60 years. ,... High Commissioner for Human Rights will be the ke...
(Date:11/20/2008)... Nov. 20 Reno,s Downtown Ballroom ...n Saturday, Nov. 15 as over 850 guests filled the ...t cherished institutions, Saint Mary,s Regional Me...many of Nevada,s prominent leaders, including Neva..., To view the Multimedia News Release, go to: ...
(Date:11/20/2008)... Nov. 10 Precision Therapeutics In...g response tests, has secured $43 million,in addi...rcialization of,ChemoFx(R). ChemoFx is a diagnos...fective chemotherapeutic regimen for cancer patien...P., led the round and was joined by existing,inve...
Breaking Medicine News(10 mins):Health News:Lactic acid found to fuel tumors 2Health News:Photos: Nevada's Saint Mary's Regional Medical Center Raises $1.3 Million During Centennial Soiree 2Health News:Precision Therapeutics Secures $43 Million in Venture Capital Funding 2Health News:Precision Therapeutics Secures $43 Million in Venture Capital Funding 3
...at the scent of roses may help in retaining memori...e University of Lubeck, led by Jan Born exposed th...ts of rose odors, while they were memorizing cards...ey were then sent off to sleep with electrodes con...
...ld diagnosed with various autism disorders are bes...of principles//. With the Centers for Disease Con... 1 in 150 children may be affected by an autism sp...r are facing concerns and questions as they send t...
...neurons and muscle cells degrades as we grow older...e attention of our muscles to move// , according t...ight, an assistant professor in UD's College of He...lated changes in muscle and neurons, elderly peopl...
... contaminated fish are enormous and especially chi...eful about how much// and which fish they eat says...blished today in a special issue of the internatio...at the Eighth International Conference on Mercury ...
Other Medicine News:Health News:Scent of a Rose may Give More Than Pleasure 2Health News:Parents Should Do Their Homework to Aid Autistic Child's Education 2Health News:Mobility can be improved in elders with exercise 2Health News:Mobility can be improved in elders with exercise 3Health News:Mobility can be improved in elders with exercise 4Health News:Methylmercury in Marine Fish Pose Health Risks to Pregnant Women and Elderly Men 2Health News:Methylmercury in Marine Fish Pose Health Risks to Pregnant Women and Elderly Men 3
(Date:11/20/2008)... , , PHILADELPHIA, Nov. 20 /PRNewswire-Fi...nounced that the United States Food and Drug Admin...ROMACTA(R) (eltrombopag) for the treatment of thro...pathic) thrombocytopenic purpura (ITP) who have ha...unoglobulins or splenectomy. The approval is a sig...
(Date:11/20/2008)...INARY TOP LINE RESULTS OF FIRST PHASE III TRIAL SH..., AND IMPROVEMENT IN DAILY FUNCTION, IN, ...LO ALTO, Calif., and BRUSSELS, Belgium, Nov. 20 /P.... (Nasdaq: JAZZ ) and UCB (Euronext Brussels: UC...results from the first of two,Phase III pivotal c...
(Date:11/20/2008)...H, Switzerland, November 20 /PRNewswire-FirstCall/...nti-infective Drugs Advisory Committee of the,U.S...to 2 against the,approval of intravenous iclaprim...treatment of patients with complicated skin and sk... caused by methicillin-resistant Staphylococcus,a...
(Date:11/20/2008)... Calif., Nov. 20 Milk. It does a b...originally thought. After years of,research, scie...es found in,cow,s milk that stimulate the body,s ...ew the Multimedia News Release, go to:, http://www... While developing new cancer therapies, the chie...
Breaking Medicine Technology:FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 3Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 4Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 5Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 6Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Photos: Peptides Discovered to Alleviate Chemotherapy Side Effects 2U S Turns Spotlight on Medicines Most Puzzling Cases 19789 1U S Turns Spotlight on Medicines Most Puzzling Cases 19789 2Erectile Dysfunction a Strong Harbinger of Heart Trouble 19786 1Erectile Dysfunction a Strong Harbinger of Heart Trouble 19786 2Erectile Dysfunction a Strong Harbinger of Heart Trouble 19786 3Tracking influenzas every movement 3362 1Tracking influenzas every movement 3362 2MR imaging accurately determines prostate cancer treatment failure 19783 1
...EW YORK, June 15, 2007 /PRNewswire/ -- Telomerase ... announced the results of,the Pivotal 2005 Anti-Ag...show demonstrated, measurable and positive anti-ag...cally significant,results were found in those taki... , -- Improvement in immune system function, ...
...UND, June 15, 2007-Active Biotech (OMX Nordic: ACT...I-3D at the annual EULAR (The,European League Agai...ww.eular.org/">www.eular.org ) conference, June,1... that I-3D has a,significant inhibitory effect on ...heumatoid arthritis (RA)", commented Sven,Andr&eac...
Other Medicine Technology:Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07,Teleconference to Answer Questions About TA-65, Their Telomerase,Activator With Proven Age Management Benefits 2New Positive Pre-clinical Data for Active Biotech's RA Project I-3D 2
An indirect immunofluorescence (IFA) antibody test for the detection and semiquantitation of anti-glomerular basement membrane (GBM) antibodies in human serum. Slide Detail: 6-well Monkey Kidney Subs
An enzyme linked immunoassay (ELISA) for the detection and semiquantitationof IgG and IgM antibodies to 2-GP1, as an aid in assessingthe risk of thrombosis in patients with Systemic Lupus Erythematos
...a from ImagingPlanet Research Microscopy Group, a...ed image resolution and precise color accuracy at ...h with this high resolution 3.3 mega-pixel digital...o-lens applications. Fully computer controlled wit...
The ImagingPlanet 80 mm surgical microscope video adapter: superior optical quality and precise engineering make this 80 mm focal length adapter an excellent decision for use with your Zeiss surgical
Medicine Products: